Editors


Dr. Luc Duchesne

About Dr. Luc Duchesne

Dr. Luc C. Duchesne is a Speaker and Author with a PhD in Biochemistry. With three decades of scientific and business experience, he has published 85 scientific papers, and has recently published his first novel, "The Moose Motel: A Tale of Golden Revenge". The Founder and CEO for GSN DreamWorks Inc. based in Ottawa, Luc is a regular columnist for InvestorIntel.

208 InvestorIntel Articles By Dr. Luc Duchesne

image_pdfimage_print

A yes vote does not make it legal to buy recreational cannabis in Canada


June 05, 2018
| June 05, 2018 | 1 Comment

The Senate of Canada is currently debating Bill C-45, the Cannabis Act, with a deadline for voting at midnight on […]


PharmaCielo and AAJ $60M raise could propagate a “stand out” among Canadian cannabis companies


May 11, 2018
| May 11, 2018

PharmaCielo Ltd., a private Canadian company with a license to cultivate and process cannabis in Columbia, announced the appointed a […]


Gratomic announces graphene tire collaboration deal with Perpetuus


April 23, 2018
| April 23, 2018 | 1 Comment

Gratomic Inc. (TSXV: GRAT) announced that it has signed a letter of collaboration (“Agreement”) with Perpetuus Carbon Technologies Limited (“Perpetuus”) […]


7th Annual InvestorIntel Summit to look into the future of buds, batteries and blockchain


April 04, 2018
| April 04, 2018 | 1 Comment

InvestorIntel members and friends will be taking a futuristic look at the B trifecta: Buds, Batteries and Blockchain (BBB) at […]


Gratomic successfully reinvents the wheel with plasma graphene


March 06, 2018
| March 06, 2018

Gratomic Inc. (TSXV: GRAT) is expecting to commercialize graphene-enhanced tires in 2018 as a result of its advanced R&D program […]


NanoSphere pioneering innovative cannabinoid delivery technology


March 05, 2018
| March 05, 2018 | 2 Comments

NanoSphere Health Sciences Inc. (CSE: NSHS) has developed an innovative delivery technology that increases up to six-fold the bioavailability of cannabinoids, […]